These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7811037)

  • 21. Selenoacyclovir and Selenoganciclovir: Discovery of a New Template for Antiviral Agents.
    Sahu PK; Umme T; Yu J; Nayak A; Kim G; Noh M; Lee JY; Kim DD; Jeong LS
    J Med Chem; 2015 Nov; 58(21):8734-8. PubMed ID: 26460883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifications on the heterocyclic base of ganciclovir, penciclovir, acyclovir - syntheses and antiviral properties.
    Chuchkov K; Chayrov R; Hinkov A; Todorov D; Shishkova K; Stankova IG
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):979-990. PubMed ID: 32312162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Plotkin SA; Drew WL; Felsenstein D; Hirsch MS
    J Infect Dis; 1985 Oct; 152(4):833-4. PubMed ID: 2995505
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiviral activity and mechanism of action of ganciclovir.
    Matthews T; Boehme R
    Rev Infect Dis; 1988; 10 Suppl 3():S490-4. PubMed ID: 2847285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.
    Wagner M; Michel D; Schaarschmidt P; Vaida B; Jonjic S; Messerle M; Mertens T; Koszinowski U
    J Virol; 2000 Nov; 74(22):10729-36. PubMed ID: 11044117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo antiherpesvirus activity of N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine.
    Neyts J; Jähne G; Andrei G; Snoeck R; Winkler I; De Clercq E
    Antimicrob Agents Chemother; 1995 Jan; 39(1):56-60. PubMed ID: 7695329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection.
    Katzenstein DA; Crane RT; Jordan MC
    J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity and pharmacokinetics of HOE 602, an acyclic nucleoside, in animal models.
    Winkler I; Winkelmann E; Scholl T; Rösner M; Jähne G; Helsberg M
    Antiviral Res; 1990 Aug; 14(2):61-73. PubMed ID: 2177317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
    Russler SK; Tapper MA; Carrigan DR
    Lancet; 1989 Aug; 2(8659):382. PubMed ID: 2569565
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of (-)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in African green monkeys infected with simian varicella virus.
    Soike KF; Bohm R; Huang JL; Oberg B
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1370-2. PubMed ID: 8392312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine.
    Smee DF; Morris JL; Leonhardt JA; Mead JR; Holy A; Sidwell RW
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1837-42. PubMed ID: 1329629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
    Debs RJ; Montgomery AB; Brunette EN; DeBruin M; Shanley JD
    J Infect Dis; 1988 Feb; 157(2):327-31. PubMed ID: 2826613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses.
    Rollinson EA; White G
    Antimicrob Agents Chemother; 1983 Aug; 24(2):221-6. PubMed ID: 6314886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
    Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
    J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Ganciclovir on murine cytomegalovirus-induced hearing loss in a mouse model.
    Qiao Y; Meng L; Wang J; Meng H
    Cell Biochem Biophys; 2011 Nov; 61(2):407-12. PubMed ID: 21584716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
    Agut H; Huraux JM; Collandre H; Montagnier L
    Lancet; 1989 Sep; 2(8663):626. PubMed ID: 2570323
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.
    Iwayama S; Ohmura Y; Suzuki K; Ono N; Nakazawa H; Aoki M; Tanabe I; Sekiyama T; Tsuji T; Okunishi M; Yamanishi K; Nishiyama Y
    Antiviral Res; 1999 Jun; 42(2):139-48. PubMed ID: 10389656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study.
    Golankiewicz B; Ostrowski T; Goslinski T; Januszczyk P; Zeidler J; Baranowski D; de Clercq E
    J Med Chem; 2001 Nov; 44(24):4284-7. PubMed ID: 11708929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.